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The randomized multicenter trials indicate that survival in 
patients with coronary artery disease and left ventricular 
dysfunction is enhanced by surgical therapy compared with 
medical therapy. This beneficial effect of coronary bypass 
surgery was demonstrated in patients with either three 
vessel or left main coronary artery disease, but not in those 
with one or two vessel disease. To determine whether 
subgroups of mildly symptomatic patients with one or two 
vessel coronary artery disease and left ventricular dysfunc- 
tion have an increased risk of death or cardiac events 
during medical therapy, 53 consecutive patients with angio- 
graphically defined one or two vessel disease and impaired 
left ventricular function (ejection fraction 20% to 40%) 
were studied by exercise electrocardiography (ECG) and 
rest and exercise radionuclide angiography. All but two 
patients had previous myocardial infarction, and all were 
asymptomatic or only mildly symptomatic during medical 
therapy. 
By univariate life table analysis, mortality during med- 
ical therapy was associated significantly with the ST seg 
ment response to exercise (p < 0.05) and with both the 
exercise ejection fraction (p < 0.05) and the magnitude of 
change in ejection fraction with exercise (p < 0.005). In 
patients with an exercise ejection fraction >30%, the 
probability of survival at 6 years was 97 + 3% (&SE) 
compared with a survival rate of 62 + 14% in the remain- 
ing subjects (p < 0.005). Similarly, 6 year survival was 
100% in patients whose ejection fraction increased from the 
value at rest but was only 74 + 10% in the remaining 
patients (p < 0.005). Exercise capacity was not associated 
with survival. The likelihood of a cardiac event (death, 
reinfarction or congestive heart failure) during medical 
treatment was also associated significantly with the exercise 
ejection fraction and magnitude of change in ejection 
fraction with exercise (both p < 0.005). Twelve of the 18 
events, including seven of the eight deaths, occurred in 
patients with two vessel disease. 
Therefore, noninvasive indexes of left ventricular func- 
tion and myocardial ischemia are important predictors of 
the clinical course of mildly symptomatic patients with two 
vessel disease and left ventricular dysfunction at rest, and 
may be used to identify subgroups of patients at risk of 
death, as well as of major cardiac events, during subse- 
quent medical therapy. 
(J Am Co11 Cardiol1989;13:567-73) 
There is convincing evidence that, in selected groups of 
mildly symptomatic patients with coronary artery disease, 
coronary artery bypass surgery increases life expectancy. 
Recent multicenter trials of medical versus surgical treat- 
ment of coronary artery disease (l-l l), as well as related 
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investigations (12-l4), have identified subgroups of patients 
whose prognosis is enhanced by surgical treatment in com- 
parison with medical therapy. Mildly symptomatic patients 
with significant stenosis of the left main coronary artery 
(1,2), as well as those with three vessel disease and left 
ventricular dysfunction at rest (6,7,1 I, 13). have improved 
long-term survival if treated surgically. 
In the Coronary Artery Surgery Study (CASS), the im- 
proved long-term survival in patients with three vessel 
disease and impaired left ventricular function was observed 
primarily in patients with exercise-induced angina, exercise- 
induced ST segment depression or reduced exercise toler- 
ance (8,15,16). This observation suggests that inducible 
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ischemia, superimposed on previous left ventricular damage, 
is of major importance in determining the prognosis of 
patients who have similar degrees of ventricular dysfunction 
at rest. If this is the case, then higher mortality rates during 
medical therapy might also be expected in patients with one 
or two vessel disease and left ventricular dysfunction who 
manifest inducible ischemia compared with rates in similar 
patients with one or two vessel disease but without inducible 
ischemia. The present investigation was undertaken to de- 
termine whether in mildly symptomatic patients with coro- 
nary artery disease and left ventricular dysfunction at rest, 
noninvasive indexes of left ventricular function and exer- 
cise-induced ischemia are related to prognosis in the sub- 
group of patients with one or two vessel disease. 
Methods 
Study patients. Between June 1976 and January 1986, we 
studied prospectively 53 consecutive asymptomatic or 
mildly symptomatic patients with angiographically defined 
one vessel or two vessel coronary artery disease and left 
ventricular dysfunction at rest, with rest ejection fraction by 
radionuclide angiography between 20% and 40%. Patients 
were included in this study if they were ~70 years of age and 
had not undergone previous coronary artery bypass surgery. 
Coronary angiograms were obtained with the percutaneous 
femoral technique in multiple left anterior oblique and right 
anterior oblique projections. Significant coronary artery 
stenosis was defined as a ~50% reduction in luminal diam- 
eter (in comparison with the diameter of the artery just 
proximal to the stenosis) of at least one epicardial coronary 
artery. Twenty-two patients (42%) had stenosis of one 
coronary artery and 3 1 (58%) of two major coronary arteries. 
There were 41 men and 12 women ranging in age from 25 to 
69 years (mean 51). Twenty-five patients had only mild 
angina pectoris (Canadian Heart Association class II), and 
the other 28 patients were completely asymptomatic during 
medical therapy. 
Fifty-one patients (96%) had evidence of a previous 
myocardial infarction, as documented by at least two of the 
three following criteria: 1) abnormal Q waves in the basal 
electrocardiogram (ECG) or clear ECG documentation of 
the acute phase of the infarction; 2) documentation of serial 
elevations of serum creatine kinase or kinase MB isoen- 
zyme; and 3) history of typical, prolonged chest pain. The 
site of the infarction was anterior (leads I, aVL, V, to V6) in 
22 patients and inferior (leads II, III, aVF) in 19; in the other 
9 patients, the site of infarction could not be localized by 
ECG, or there was evidence of multiple infarctions or of 
non-Q wave infarction. 
All patients underwent exercise ECG and rest and exer- 
cise radionuclide angiography. Coronary arteriography was 
performed within 1 month of radionuclide angiography and 
exercise testing in all but eight patients; within 6 months of 
exercise studies in four of these latter eight patients and 
within 12 months in the other four patients. Three of these 
four patients subsequently underwent repeat coronary arte- 
riography with confirmation of the previous results; the 
patient who did not undergo repeat coronary arteriography 
had two vessel disease. In this particular patient, angina did 
not change in intensity or frequency during the interval 
between noninvasive studies and coronary arteriography. 
Exercise testing. All exercise studies were performed 
after withdrawal of all cardiac medications and, in particular, 
~48 h after discontinuation of propranolol and calcium 
channel blocking drugs and ~12 h after discontinuation of 
nitrate preparations. 
Gated blood pool cardiac scintigraphy. Rest and symp- 
tom-limited exercise radionuclide angiograms were obtained 
in the supine position. Exercise studies were performed with 
a bicycle ergometer beginning at a work load of 25 W. Work 
loads were increased by 25 W increments every 2 min; heart 
rate and blood pressure measured by sphygmomanometry 
were monitored during exercise. Imaging was begun early 
after the start of exercise, but only that portion of the data 
obtained during maximal exercise was selected for analysis. 
Left ventricular ejection fraction was determined by com- 
puter analysis of the scintigraphic data, as previously de- 
scribed (17). 
Exercise electrocardiography. The patients performed 
symptom-limited exercise after withdrawal of medications 
during the same week as radionuclide angiography. We used 
an upright bicycle ergometer in 46 patients; work loads were 
increased by 20 W increments every 3 min. To determine the 
initial work load for this test, two training sessions were 
carried out for every patient, and the initial work load for the 
final test was chosen such that an end point could be reached 
after 3 to 5 min of exercise (l&19). The remaining seven 
patients underwent treadmill exercise testing. In the absence 
of any symptoms, tests were interrupted when heart rate 
reached 85% of the predicted maximal value for age and 
gender. Two bipolar ECG leads were monitored during 
exercise, as previously described (20); ECGs were obtained 
at rest, during exercise and for 5 min after termination of 
exercise. ST segment depression was measured 0.08 s after 
the J point; only flat or downsloping depressions of ST 
segment ~0.1 mV were considered ischemic changes. In 
patients with ST segment abnormalities at rest, a further 
decrease in ST segment of ~0.1 mV was also considered an 
abnormal response. ST segment interpretation was not pos- 
sible in five patients because of excessive baseline artifacts 
(four patients) or bundle branch block (one patient). 
Ambulatory electrocardiographic monitoring. In a subset 
of 34 patients, 24 h ECG recordings were obtained, as 
previously described (21). This procedure was performed 
after withdrawal of all medications. 
Follow-up evaluation. During the course of this study, 
coronary artery bypass surgery or percutaneous coronary 
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Table 1. Association Between Noninvasive Exercise Data and Subsequent Clinical Course in 
53 Patients 
Age (yr) 
Gender 
Exercise ECG testing 
ST segment response 
Exercise capacity 
Angina during exercise 
Radionuclide angiography 
LVEF at rest 
LVEF during exercise 
LVEF response to exerciset 
Ambulatory ECG monitoring 
Lown class 
Presence of ventricular tachycardia 
Length of ventricular tachycardia 
Deaths 
(8 events): 
p Value 
0.72 
0.79 
0.03* 
0.19 
0.14 
0.41 
0.02* 
0.003* 
0.42 
0.76 
0.51 
Death or 
Reinfarction 
1 IO events): 
p Value 
0.87 
0.84 
0.02* 
0.09 
0.32 
0.48 
0.04* 
0.006* 
0 77 
0.72 
0.96 
Death, CHF or 
Reinfarction 
(15 events): 
p Value 
0.69 
OS2 
0.12 
0.02 
0.65 
0.08 
0.003* 
0.003* 
0.96 
0.94 
0.88 
Any Cardiac 
Event 
(18 events): 
p Value 
0.82 
0.37 
0.02* 
0.02* 
0.39 
0.23 
0.007” 
0.002” 
0.56 
0.45 
0.37 
*Significant value by Cox univariate analysis (22); tejection fraction during exercise minus ejection fraction at 
rest. CHF = congestive heart failure: ECC = electrocardiographic; LVEF = left ventricular ejection fraction. 
angioplasty was performed only when angina increased in 
severity and became symptomatically limiting despite ther- 
apy with beta-adrenergic blocking drugs, nitrate prepara- 
tions and, since 1980, calcium channel blocking drugs. 
Patients who became candidates for operation on the basis of 
increasing symptoms were admitted for repeat coronary 
arteriography. 
Statistical analysis. The ability of noninvasive data to 
predict the subsequent clinical course during medical ther- 
apy was assessed by Cox regression analysis (22). The 
noninvasive variables considered in this analysis included 
gender, age, rest and exercise ejection fraction, magnitude of 
change in ejection fraction during exercise (exercise value 
minus rest value), exercise capacity (expressed in watts), ST 
segment response to exercise, reasons for terminating exer- 
cise, and the presence or absence of ventricular tachycardia 
and Lown class of ventricular arrhythmias (23) on ambula- 
tory ECG monitoring. Cardiac events in this analysis in- 
cluded: 1) death during medical treatment, 2) death, reinfarc- 
tion or congestive heart failure, and 3) death, reinfarction, 
congestive heart failure or increasing angina requiring sur- 
gery. Congestive heart failure was defined as the develop- 
ment of dyspnea under rest conditions (New York Heart 
Association functional class IV). Patients who underwent 
coronary bypass surgery were censored from the survival 
and survival plus reinfarction or heart failure analyses at the 
date of surgery. We plotted survival curves using the method 
of Kaplan and Meier (24); the differences among subgroups 
were analyzed with use of the Mantel-Haenszel test (25). We 
used discriminant analysis (26) to determine the best cutoff 
limits for exercise left ventricular ejection fraction and 
exercise capacity with which to subgroup patients for this 
analysis. 
Results 
Patient experience. During the course of medical therapy 
with a mean follow-up of 56 t 30 months, eight patients 
died: four patients died suddenly (three with two vessel and 
one with one vessel disease); two patients (both with two 
vessel disease) died from refractory heart failure after re- 
infarction: and two patients (both with two vessel disease) 
died from unknown causes in the absence of witnesses. One 
of these latter deaths was thought to be of cardiac origin 
because the patient developed progressive symptoms of 
heart failure and angina during medical treatment and had no 
other known life-threatening illnesses. The remaining patient 
disappeared while sailing. 
Three patients had a nonfatal myocardial reinfarction and 
seven developed overt heart failure. Including the eight 
deaths, I5 patients had at least one of these major cardiac 
events. Four of these patients and an additional three other 
patients underwent bypass surgery for increasing symptoms. 
Determinants of prognosis. The association by univariate 
Cox regression analysis between the noninvasive exercise 
data and these end points is shown in Table 1. Only the ST 
segment response (p < 0.05) and the radionuclide angio- 
graphic variables, including the ejection fraction during 
exercise (p < 0.05) and the magnitude of change in ejection 
fraction with exercise compared with the rest value (p < 
O.OOS), were associated significantly with death during med- 
ical therapy. In addition, both of the exercise radionuclide 
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Table 2. Clinical Course in 53 Patients With One Vessel or Two Vessel Disease 
Number of 
Patients 
Percent Alive 
at 6 Years p Value 
Percent Alive 
at 6 Years 
Without CHF 
or Reinfarction p Value 
Percent Alive at 
6 Years Without 
Cardiac Events p Value 
All patients 
Exercise EF 
>30% 
530% 
Change in EF with exercise 
Increase 
No change or decrease 
ST segment response to exercise 
Normal (CO. 1 mV) 
Abnormal (20.1 mV) 
Exercise capacity 
2100 w 
<lOOW 
53 86 t 5 83 ? 6 69 2 7 
36 97 + 3 89 k 5 81 k 7 
<o.oos* <o.oos* <0.005* 
17 62 + 14 41* 13 44k 12 
22 100 95 k 4 89 k 7 
<0.005* <0.005* <o.OJX* 
31 74 + 10 60 + 9 53 k 10 
33 90 + 5 71 k 8 71 * 8 
0.15 0.36 0.057 
IS 75 + 13 71 + 2 50 * 14 
26 91 ? 7 71 2 9 80 L 8 
0.33 0.11 0.059 
20 84 k 8 692 11 55 * 12 
*Significant values by Mantel-Haenszel test (24). EF = ejection fraction; other abbreviations as in Table I. Values shown are mean values + SE. 
angiographic variables as well as the ST segment response 
and exercise capacity were associated with death, heart 
failure, reinfarction or increased angina requiring surgical 
intervention. 
When the patients were classified into discrete subgroups 
to evaluate survival and cardiac event trends during the 
follow-up period (Table 2), both the exercise ejection frac- 
tion and the magnitude of change in ejection fraction during 
exercise compared with the value at rest were associated 
significantly with survival. In patients with an ejection 
fraction during exercise >30%, the survival at 6 years was 
97% k 3% compared with 62% 2 14% in patients with an 
exercise ejection fraction of 530% (p < 0.005) (Fig. l), 
representing annual mortality rates of 0.5% and 6.3%, re- 
spectively. Similarly, the 6 year survival rate of patients 
whose ejection fraction increased with exercise compared 
with the value at rest was excellent (100%) and significantly 
greater than that of patients whose ejection fraction was 
unchanged or decreased during exercise (Table 1, Fig. 1); the 
respective annual mortality rates in these subgroups were 
0% and 4.3%. When patients were classified on the basis of 
left ventricular ejection fraction at rest, presence or absence 
of ST segment depression with exercise, or exercise capac- 
ity, no significant differences in survival were observed 
among subgroups. 
The radionuclide angiographic data during exercise re- 
mained signijcantly related to the outcome when myocar- 
dial infarction and congestive heart failure in addition to 
death were considered (Table 2) as was the case when 
Figure 1. Influence of left ventricular ejection fraction (EF) during 
exercise and the ejection fraction response to exercise on subse- 
quent survival during medical treatment. Top, Survival of patients 
with an ejection fraction during exercise >30% is compared with 
that of patients with ejection fraction 530%. Bottom, Survival in 
patients with an increase in ejection fraction relative to the value at 
rest is compared with that of patients in whom ejection fraction was 
unchanged or decreased during exercise. Bars indicate *SE. 
40 -+ Exercise EF 230% (n = 36) 
4 
5 
+ Exercise EF ~30% (n = 17) 
p <o.w5 
EF Response lo Exercise: 
--- Increase (rl = 22) 
- Decrease or No Change (n = 31) 
0 
0 10 20 30 40 50 60 70 
MONTHS 
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Figure 2. Influence of left ventricular ejection fraction (EF) response 
during exercise and the likelihood of death, reinfarction or heart 
failure. Patients are classified as in Figure I. 
increased angina requiring surgery was also included in the 
analysis. In patients with greater functional abnormalities 
during exercise, the risk of death, reinfarction or heart 
failure within 6 years was very high (Table 2, Fig. 2); within 
6 years, 53% of patients with an exercise ejection fraction 
~30% experienced such cardiac end points, as did 40% of 
patients whose ejection fraction failed to increase during 
exercise compared with the rest value. 
Patients with two vessel disease. Twelve of the 18 cardiac 
events, including seven of the eight deaths, occurred in the 
31 patients with two vessel disease. Because of the small 
number of events, no variable was predictive of outcome in 
patients with one vessel disease. An analysis of the patients 
with two vessel disease, however, indicated that survival 
was significantly associated with the magnitude of change in 
ejection fraction during exercise compared with the rest 
value (p = 0.03). The ST segment response (p = 0.15) and 
the ejection fraction during exercise (p = 0.06) were not 
associated significantly with survival. 
When patients with two vessel disease were classijed into 
discrete subgroups, survival trends were similar to those 
observed in the total cohort of patients with either one vessel 
or two vessel disease. Patients with two vessel disease and 
exercise ejection fraction >30% had higher 6 year survival 
rates than did those with exercise ejection fraction of ~30% 
(95% + 5% versus 58% t 16%, p < 0.05). Similarly, patients 
manifesting an increase in ejection fraction during exercise 
compared with rest values had higher 6 year survival rate 
than did those whose ejection fraction was unchanged or 
decreased (100% versus 67% + 13%, p < 0.05). 
Effect of left anterior descending coronary artery stenosis. 
Thirty-nine (74%) of the 53 patients had stenosis of the left 
anterior descending artery, including 14 (64%) of the 22 
patients with one vessel disease and 25 (81%) of the 31 
patients with two vessel disease. All deaths occurred in 
patients with stenosis of the left anterior descending artery. 
Because of the small number of patients without involve- 
ment of this artery (14 patients), a comparison of patients 
with versus those without such stenosis was not performed. 
Discussion 
Among patients with coronary artery disease, survival is 
reduced in patients with left ventricular dysfunction at rest 
compared with that in patients with preserved left ventricu- 
lar function (3,27,28). Recently, investigators in the CASS 
(7,ll) and Veterans Administration (6) trials and in the 
Seattle Heart Watch (13) have demonstrated that, in mildly 
symptomatic patients with three vessel disease and left 
ventricular dysfunction at rest, survival may be enhanced by 
coronary bypass surgery. Survival is also improved by 
surgery in patients with left main coronary artery disease 
and depressed left ventricular function (1,2). However, 
enhanced survival by surgical therapy has not been demon- 
strated in mildly symptomatic patients with one or two 
vessel disease and impaired left ventricular function (6,13). 
The purpose of the current investigation was to determine 
whether there are subgroups of mildly symptomatic patients 
with left ventricular dysfunction and either one or two vessel 
disease who have an increased risk of death, reinfarction or 
heart failure during medical therapy. 
Exercise-induced ischemia and prognosis. Our data indi- 
cate that the left ventricular functional response during 
exercise is predictive of prognosis in patients with one or 
two vessel disease and left ventricular dysfunction. Those 
patients with no change or a decrease in ejection fraction 
during exercise are at high risk of dying (Fig. 1) or of 
experiencing a major cardiac event (Fig. 2), whereas those 
whose ejection fraction increases during exercise compared 
with the value at rest are at low risk during medical therapy, 
despite impaired left ventricular function. In this regard, 
ejection fraction was lower during exercise than at rest in all 
patients in our series who died during the follow-up period, 
and was ~30% during exercise in all but one patient. 
Although the ST segment response in our study was also 
associated with outcome (Table 1). other variables derived 
from exercise testing, such as exercise capacity or the 
development of angina pectoris, were not helpful in selecting 
subgroups at greater risk of dying during the follow-up 
period. The degree of left ventricular dysfunction at rest and 
ventricular arrhythmias on ambulatory monitoring were also 
not associated with subsequent outcome. 
In more symptomatic patients with wider ranges of left 
ventricular function at rest, Pryor et al. (29) also observed 
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that exercise ejection fraction was the variable most closely 
associated with future cardiac events; and Higginbotham et 
al. (30) demonstrated in unselected patients with coronary 
artery disease and an ejection fraction of <50% that a 
decrease in ejection fraction with exercise was significantly 
associated with late mortality during medical treatment. In 
neither of these two studies were the data in patients with 
one vessel or two vessel disease analyzed separately, and 
patients with moderate to severe symptomatic limitation 
were included in both studies. Data derived from the CASS 
randomized trial (7) in patients with left ventricular dysfunc- 
tion did not identify high risk and low risk subgroups with 
one or two vessel disease. However, the number of such 
patients undergoing randomization in that multicenter trial 
was quite small: only 11 patients with one vessel disease and 
35 patients with two vessel disease were randomized to 
medical treatment in the CASS study (fewer patients than in 
our study). In that investigation, moreover, exercise studies 
were not performed in all patients. Of the patients who did 
exercise, medications were not routinely discontinued and 
the left ventricular functional response to exercise was not 
assessed. 
Recent data from the CASS registry (15,16) indicate that 
the patients with three vessel disease and impaired left 
ventricular function who manifest the poorest survival (and 
also greatest benefit from surgery) are those patients with ST 
segment abnormalities induced at low work loads of tread- 
mill exercise. These data suggest that inducible myocardial 
ischemia superimposed on previous left ventricular damage 
is of major importance in determining prognosis in such 
patients. Our data indicate that similar factors influence 
prognosis in patients with left ventricular dysfunction and 
two vessel disease. 
Limitations of the study. Several limitations of our study 
should be addressed. Because seven of the eight deaths 
occurred in patients with two vessel disease, our data are 
inconclusive in those with one vessel disease. All deaths in 
our series occurred in patients with stenosis of the left 
anterior descending artery, but the small number of patients 
without such involvement did not allow us to test the 
possibility that left anterior descending disease adversely 
affects prognosis in patients with left ventricular dysfunction 
at rest. Medical therapy was not standardized in a rigorous 
fashion in that patients received a variety of beta-adrenergic 
blocking drugs, calcium channel blockers and nitrate prepa- 
rations in different doses. Aspirin and lipid-lowering drugs 
were not used consistently. Such limitations in medical 
therapy are present in the multicenter randomized trials as 
well. Because our data were derived from a relatively small 
patient sample with a limited number of deaths our conclu- 
sions must be considered tentative until confirmed by a 
larger series. Finally, we do not have data on a correspond- 
ing series of patients undergoing coronary bypass surgery to 
demonstrate whether surgery improves survival in our high 
risk groups. 
Conclusions. Despite these limitations, our results indi- 
cate that the left ventricular functional response to exercise 
provides critically important data for determining the risk 
stratification of mildly symptomatic patients with two vessel 
disease and left ventricular dysfunction at rest and may 
prove of value in identifying such patients, as well as those 
with three vessel disease, who warrant more aggressive 
management. 
We thank lmogene Surrey and Maude Atcheson for excellent editorial 
assistance. 
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